Comparing two methods to reduce stress responses during traumatic memory recall

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the effectiveness of a novel intervention that combines memory reactivation with the beta-blocker propranolol to reduce physiological responses to traumatic memories. Participants who have experienced a traumatic event will be randomized into two groups: one receiving standard treatment and the other receiving a treatment that includes a 'mismatch' component designed to enhance memory deconsolidation. The study will measure participants' heart rate, skin conductance, and muscle responses during guided imagery of their traumatic experiences to assess the impact of the interventions. The goal is to determine if the mismatch approach leads to greater reductions in stress reactivity compared to standard methods.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Initial participants will be males or females 18-65 years old who have experienced a traumatic event that meets the DSM-5 PTSD A criterion, and whose PCL-5 score is \>33 (to maximize the likelihood that they will meet our psychophysiological inclusion criterion). In order to be randomized, participants must further meet this psychophysiological inclusion criterion during baseline script-driven imagery testing Although we do not require a diagnosis of PTSD, because we have set a minimum psychophysiological inclusion criterion and a valid Criterion A traumatic event, our sample will include a substantial number, likely a majority, of PTSD participants.

Exclusion Criteria:

1. Basal sitting or standing systolic blood pressure \<90/60 mm Hg or basal HR \<50 BPM. Those participant-candidates excluded for this reason with such readings will be counseled and referred for further clinical consultation if symptomatic or if they wish to be referred even if asymptomatic.
2. Medical condition that contraindicates PPNL, e.g., congestive heart failure, heart block, insulin- requiring diabetes, chronic bronchitis, emphysema, or asthma. Asthma attacks will only be exclusionary if they: a) occurred within the past ten years, b) occurred at any time in life if induced by a β-blocker, or c) are currently being treated
3. Previous adverse reaction to, or non-compliance with, a β-blocker
4. Current use of medication that may involve potentially dangerous or confounding interactions with PPNL, including anti- hypertensives, antiarrhythmics, and benzodiazepines. (Possible inhibition of CYP2D6 isoenzyme-dependent reactions will not be of concern in this study, because PPNL will only be administered once a week)
5. Presence of drugs of abuse, including opiates, marijuana, cocaine, amphetamines, or alcohol at the initial assessment
6. Pregnancy or breast feeding. Women of childbearing potential will have a pregnancy test at the initial assessment
7. Presence of a contraindicating psychiatric condition, e.g., psychotic, bipolar, melancholic, or active substance use disorder; or suicidality (see below)
8. Initiation of, or change in, psychotropic medication within the previous two months. For participants receiving stable doses of pharmacotherapy, they and their clinicians-prescribers will be asked not to alter the regimen during the proposed two-month study period (excluding the one-month follow-up) except in clinically urgent circumstances. If this becomes necessary, a decision will be made on a case-by-case basis about retaining the participant or terminating participation
9. Current participation in any psychotherapy other than supportive. Participants will be asked not to initiate new psychotherapy during the proposed two-month study period (excluding the one-month follow-up) except in clinically urgent circumstances. If this becomes necessary, a decision will be made on a case-by-case basis about retaining the participant or terminating participation
10. Inability to understand the study's procedures, risks, and side effects, or to otherwise give informed consent for participation
11. Participant candidate does not understand English. This exclusion criterion is necessary because the procedures require a nuanced dialogue with English-speaking investigators.

Where it's running

• Massachusetts General Hospital Home Base Program
  Charlestown, Massachusetts, United States Recruiting

Study contacts

• Study coordinator: James Cappellucci
• Email: jcappellucci@partners.org
• Phone: 857.282.1724

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Trauma-focused group therapy for adults with trauma symptoms in primary care

  A group-based trauma therapy delivered in primary care to see if it helps adults with trauma-related symptoms more than usual care.

  Recruiting University Ramon Llull · Barcelona, Barcelona · NCT07757334

• Preventive Narrative Exposure for PTSD After Cardiac Surgery in the ICU

  In adults having cardiopulmonary bypass heart surgery, this trial tests whether an ICU-based narrative exposure intervention helps prevent posttraumatic stress symptoms compared with standard care.

  Recruiting First Affiliated Hospital of Fujian Medical University · Fuzhou, Fujian · NCT07632131

• MOCHA: Inpatient Mental Health Care for High-Risk Pregnancy

  This study tests a collaborative mental health program for pregnant or recently postpartum patients hospitalized for medical problems to see if it can be delivered feasibly and acceptably.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07540585

• Energy Resonance by Skin Stimulation to reduce stress after ICU hospitalization

  This trial will try Energy Resonance by Skin Stimulation (ERCS), a noninvasive skin‑touch technique, to see if it lowers perceived stress in adults recovering in a post‑ICU rehabilitation unit.

  Recruiting Hôpital Européen Marseille · Marseille · NCT07422077

• SMART treatment for youth with complex trauma

  This trial tests whether Sensory Motor Arousal Regulation Treatment (SMART) helps kids aged 7–17 with developmental trauma more than usual therapy.

  Recruiting at 4 sites Vestre Viken Hospital Trust · Asker, Akershus and 3 other locations · NCT07200713

• Adaptive Cognitive Processing Therapy (CPT) Therapist Training

  This project tests different sequences of training methods to find the best way to help VA therapists learn and stick to Cognitive Processing Therapy so Veterans with PTSD get higher-quality care.

  Recruiting at 4 sites VA Office of Research and Development · Palo Alto, California and 3 other locations · NCT07010770

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.